Loading...
XASXOPL
Market cap2mUSD
Dec 20, Last price  
0.02AUD
1D
0.00%
1Q
25.00%
Jan 2017
-98.18%
Name

Opyl Ltd

Chart & Performance

D1W1MN
XASX:OPL chart
P/E
—
P/S
9.71
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
58.73%
Rev. gr., 5y
-15.57%
Revenues
398k
-35.65%
000250,00000000482,31863,46456,037219,454413,561927,041620,783767,719902,413617,907397,637
Net income
-3m
L+81.33%
-997,323-6,850,202-2,382,000-1,509,000-73,675,4113,181,851-321,892-4,338,330-2,019,486-2,666,040-4,476,738-6,083,488-3,228,403-3,035,627-3,105,138-925,847-1,143,432-2,085,550-1,726,335-3,130,374
CFO
-2m
L+50.75%
00-1,556,000-2,524,000-3,270,15700000-429,251-3,116,273-2,878,576-2,864,093-2,102,857-1,028,991-903,649-1,519,612-1,364,312-2,056,674
Earnings
Feb 26, 2025

Profile

Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials; and social media marketing agency services, such as client and account management services for pharmaceutical, medtech, and biotech industries. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.
URL
https://www.shareroot.co/
IPO date
Mar 07, 1996
Employees
3
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
398
-35.65%
618
-31.53%
902
17.54%
Cost of revenue
5,420
2,949
3,347
Unusual Expense (Income)
NOPBT
(5,023)
(2,331)
(2,445)
NOPBT Margin
Operating Taxes
(531)
(570)
(361)
Tax Rate
NOPAT
(4,492)
(1,761)
(2,083)
Net income
(3,130)
81.33%
(1,726)
-17.22%
(2,086)
82.39%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,850
808
BB yield
-43.35%
-44.01%
Debt
Debt current
115
Long-term debt
Deferred revenue
Other long-term liabilities
13
35
Net debt
(375)
(338)
(786)
Cash flow
Cash from operating activities
(2,057)
(1,364)
(1,520)
CAPEX
(18)
(2)
(10)
Cash from investing activities
(18)
(2)
(10)
Cash from financing activities
1,996
1,033
FCF
(4,723)
(1,413)
(2,086)
Balance
Cash
375
453
786
Long term investments
2
Excess cash
355
422
741
Stockholders' equity
(90)
(404)
267
Invested Capital
140
313
35
ROIC
ROCE
5,579.54%
2,577.39%
EV
Common stock shares outstanding
170,715
83,472
56,700
Price
0.03
13.64%
0.02
-53.19%
0.05
-73.89%
Market cap
4,268
132.41%
1,836
-31.09%
2,665
-64.84%
EV
3,893
1,498
1,879
EBITDA
(5,023)
(2,305)
(2,419)
EV/EBITDA
Interest
426
2
2
Interest/NOPBT